The rising prevalence in GLP-1 agonists for metabolic health has generated a debate about application forms : transdermal systems versus tablets . Usually , GLP-1 therapies were only available in pill https://sidneygprz207174.alltdesign.com/glp-1-transdermal-delivery-systems-vs-oral-medications-what-best-for-the-patient-59688156